--- title: "Bio-Techne Insider Move: Major Director Stock Sale Raises Eyebrows on Wall Street" type: "News" locale: "en" url: "https://longbridge.com/en/news/286184552.md" description: "Bio-Techne (TECH) director Amy E. Herr sold 6,636 shares for $320,386 on May 12, 2026, raising concerns among investors. Following a weak fiscal Q3 report, analysts from multiple firms adjusted their target prices, reflecting slower organic growth and a cautious outlook. Despite maintaining overall ratings, the stock is under pressure due to mixed performance. Spark's AI Analyst rates TECH as Neutral, highlighting strong financial resilience but bearish technicals and a high valuation. Year-to-date, the stock has declined by 19.26%, with a current market cap of $7.57B." datetime: "2026-05-13T02:15:45.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286184552.md) - [en](https://longbridge.com/en/news/286184552.md) - [zh-HK](https://longbridge.com/zh-HK/news/286184552.md) --- # Bio-Techne Insider Move: Major Director Stock Sale Raises Eyebrows on Wall Street New insider activity at Bio-Techne ( (TECH) ) has taken place on May 12, 2026. ### Claim 55% Off TipRanks - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Director Amy E. Herr has recently sold 6,636 shares of Bio-Techne stock in a transaction totaling $320,386, signaling a notable insider move that may draw the attention of investors tracking executive trading activity in the company. **Recent Updates on TECH stock** Bio-Techne shares faced multiple target cuts over the last 24 hours as analysts recalibrated expectations after a weak fiscal Q3 revenue picture. While EPS met consensus, organic growth missed, and management’s Q4 guidance for flat organic growth came in below prior expectations, prompting updated models that reflect softer near-term demand. Across firms including Deutsche Bank, Baird, Stifel, Evercore ISI, and Citi, the revisions largely stem from this combination of slower projected organic growth and cautious company outlook. These moves suggest the Street is acknowledging mixed performance, with pressure on sales outweighing support from solid margins, and resetting valuation frameworks accordingly, even as overall ratings were mostly maintained rather than radically revised. **Spark’s Take on TECH Stock** According to Spark, TipRanks’ AI Analyst, TECH is a Neutral. TECH scores best on financial resilience (strong cash generation and low leverage), which helps offset weaker near-term fundamentals (margin compression and a sharp TTM revenue decline). The overall score is held back by bearish technicals (price below key moving averages with negative momentum) and a demanding valuation (high P/E with a low dividend yield). Earnings-call guidance was cautiously supportive on margin and a potential FY-2027 growth inflection, but near-term growth remains limited. To see Spark’s full report on TECH stock, click here. **More about Bio-Techne** **YTD Price Performance:** -19.26% **Average Trading Volume:** 2,482,071 **Technical Sentiment Signal:** Strong Sell **Current Market Cap:** $7.57B ### Related Stocks - [TECH.US](https://longbridge.com/en/quote/TECH.US.md) - [DB.US](https://longbridge.com/en/quote/DB.US.md) - [DBK.DE](https://longbridge.com/en/quote/DBK.DE.md) - [SF.US](https://longbridge.com/en/quote/SF.US.md) - [EVR.US](https://longbridge.com/en/quote/EVR.US.md) - [C.US](https://longbridge.com/en/quote/C.US.md) - [03KB.DE](https://longbridge.com/en/quote/03KB.DE.md) - [DPB.DE](https://longbridge.com/en/quote/DPB.DE.md) - [SF-C.US](https://longbridge.com/en/quote/SF-C.US.md) - [SFB.US](https://longbridge.com/en/quote/SFB.US.md) - [SF-B.US](https://longbridge.com/en/quote/SF-B.US.md) - [SF-D.US](https://longbridge.com/en/quote/SF-D.US.md) - [C-R.US](https://longbridge.com/en/quote/C-R.US.md) ## Related News & Research - [Bio-Techne Q3 2026 Results Show Mixed Performance](https://longbridge.com/en/news/285366916.md) - [How Beaten-Down Tempus AI Stock Offers a Lottery Ticket for Traders Here](https://longbridge.com/en/news/286786866.md) - [22:13 ETGLOB Investors Have Opportunity to Lead Globant S.A. Securities Fraud Lawsuit](https://longbridge.com/en/news/286842370.md) - [03:15 ETCIGL, YOOV Deadline: CIGL, YOOV Investors Have Opportunity to Lead Concorde International Group Ltd. Securities Fraud Lawsuit](https://longbridge.com/en/news/287021785.md) - [20:11 ETLU Deadline: LU Investors Have Opportunity to Lead Lufax Holding Ltd Securities Fraud Lawsuit First Filed by the Firm](https://longbridge.com/en/news/286979305.md)